Mankind Pharma Secures CCI Approval for ₹13,360 Crore Bharat Serums Acquisition

Oct 2, 2024, 02:01 AM

Mankind Pharma has received approval from the Competition Commission of India (CCI) for its acquisition of Bharat Serums and Vaccines Limited. The acquisition deal is valued at ₹13,360 crore (approximately $1.6 billion), though some reports indicate a value of Rs 13,630 crore. This transaction involves Mankind Pharma acquiring 100% shareholding of Bharat Serums and Vaccines Limited. Mankind Pharma is India's fourth-largest drug maker.